Medical Director, Inflammatory Bowel Disease Center
The Ohio State University Wexner Medical Center
Dr. Anita Afzali is an Associate Professor of Clinical Medicine and a Gastroenterologist that specializes in Inflammatory Bowel Disease (IBD) at The Ohio State University Wexner Medical Center. She is the Medical Director of the OSU Inflammatory Bowel Disease Center and holds the Abercrombie & Fitch Endowed Chair in Inflammatory Bowel Disease. She received her medical degree from the University of Washington, then completed her Internal Medicine residency and Gastroenterology fellowship at the University of Washington in Seattle, WA. While in fellowship, Dr. Afzali worked in outcomes research and epidemiology, and also graduated with a Master’s in Public Health (MPH). Her sub-specialty training includes a one-year advanced IBD fellowship at the University of Washington, prior to becoming faculty at UW Medicine. While practicing at the University of Washington – Harborview Medical Center, Dr. Afzali served as the Director of the IBD Program and Associate Medical Director of the UW-HMC Gastroenterology Clinics. Her research interests include clinical outcomes and risks of IBD therapy, pharmacoeconomics, impact of race/ethnicity in IBD, pediatric-to-adult transition, and women of childbearing age with IBD. In collaboration with Seattle Children’s Hospital, she developed the first Pediatric to Adult IBD Transition Clinic in the Northwest. She has had extensive peer-reviewed publications, an invited lecturer on national and international programs, and serves on several national and international advisory boards and several committees including a Co-Chair of the Crohn’s & Colitis National Professional Education Committee (NPEC) and Member of the American College of Gastroenterology (ACG) Minority Affairs and Cultural Diversity committee.
Friday, April 5
11:45 AM – 12:25 PM